Global Interventional Cardiology and Peripheral Vascular Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In 2020, Edward Lifesciences Corporation (US) has received Chinese regulatory approval for the SAPIEN 3 Transcatheter Heart Valve for the treatment of patients suffering from severe, symptomatic aortic stenosis (AS) who are unable to undergo open-heart surgery

• In 2020, Biotronk SE & Co. KG, Received CE approval for its Orsiro Mission Drug-eluting Stent.

Product segmentation covers a variety of devices used in interventional cardiology and peripheral vascular procedures. This includes coronary stents, angioplasty balloons, guidewires, catheters, and atherectomy devices, as well as more advanced technologies such as drug-eluting stents and bioresorbable vascular scaffolds. Peripheral vascular devices encompass a range of tools used for the treatment of peripheral artery disease, such as peripheral stents, balloons, and access devices. Each product type plays a significant role in facilitating minimally invasive procedures, improving patient outcomes, and enhancing procedural efficiency.

Procedure segmentation looks at the different types of interventions performed using these devices. This includes coronary interventions like percutaneous coronary interventions (PCI), balloon angioplasty, stent placement, and atherectomy. Peripheral vascular procedures cover interventions such as angioplasty, stenting, and thrombectomy, aimed at restoring blood flow in the peripheral arteries. The types of procedures offered are critical for addressing various vascular diseases, from coronary artery disease (CAD) to peripheral artery disease (PAD), enhancing patient quality of life and reducing the risk of severe complications like heart attacks and limb amputation.

Indication segmentation examines the specific medical conditions that these devices and procedures target. For instance, coronary interventions are indicated for conditions like coronary artery disease, angina, and acute coronary syndrome, while peripheral vascular procedures are primarily indicated for peripheral artery disease, which can lead to reduced blood flow, pain, and tissue damage in the limbs. Understanding the indications is essential for developing targeted treatments that meet the specific needs of patients and contribute to improved clinical outcomes.

End user segmentation provides insights into the types of facilities that utilize interventional cardiology and peripheral vascular devices. This includes hospitals, specialized cardiology centers, outpatient clinics, and ambulatory surgical centers. Hospitals, being primary settings for complex procedures, are significant consumers of these devices due to their capacity to handle a variety of interventional cases and advanced surgical techniques. Other end users like outpatient and specialized centers focus on less complex procedures and routine treatments, contributing to the broader adoption of minimally invasive techniques in cardiovascular care.

Geography segmentation outlines the market distribution across different regions, which helps identify trends and growth opportunities in specific areas. North America and Europe are known for advanced healthcare infrastructure and high adoption rates of interventional procedures, whereas regions like Asia-Pacific are experiencing rapid growth due to improving healthcare access and population aging. Emerging markets in Latin America and the Middle East and Africa show potential for growth, driven by increased healthcare investments and the rising prevalence of cardiovascular diseases. Understanding geographic segmentation aids in strategic planning for market players looking to expand or reinforce their presence in specific regions.

Global Interventional Cardiology and Peripheral Vascular Devices Segment Analysis

In this report, the Global Interventional Cardiology and Peripheral Vascular Devices Market has been segmented by Product, Procedure, Indication, End User and Geography.

Global Interventional Cardiology and Peripheral Vascular Devices Market, Segmentation by Product

The Global Interventional Cardiology and Peripheral Vascular Devices Market has been segmented by Product into Coronary Stents, Percutaneous, Transluminal Coronary Angioplasty (PTCA) Balloon Catheters, Peripheral Vascular Stents, Angioplasty Catheters, Guidewires, Atherectomy Devices, Embolic Protection Devices, Vascular Closure Devices and Others.

Among these, coronary stents stand out as one of the primary interventions for managing coronary artery disease. These small mesh-like tubes are inserted into narrowed or blocked arteries to help keep them open, thereby restoring blood flow to the heart muscle. The market for coronary stents is driven by factors such as the rising prevalence of coronary artery diseases, technological advancements leading to the development of drug-eluting stents, and an increasing aging population prone to cardiovascular ailments.

Another essential product segment in this market is percutaneous transluminal coronary angioplasty (PTCA) balloon catheters. These devices are used to widen narrowed or blocked arteries in the heart by inflating a balloon at the tip of the catheter. PTCA balloon catheters are instrumental in restoring blood flow to the heart and relieving symptoms of coronary artery disease. The market for PTCA balloon catheters is propelled by the growing demand for minimally invasive procedures, coupled with advancements in balloon catheter technologies enhancing their effectiveness and safety.

Peripheral vascular stents constitute another significant segment in the interventional cardiology and peripheral vascular devices market. These stents are designed to open narrowed or blocked arteries in the peripheral vasculature, outside the coronary arteries, to improve blood flow to the legs, arms, kidneys, or other organs. The market for peripheral vascular stents is fueled by factors such as the increasing incidence of peripheral artery diseases (PAD), technological advancements leading to the development of drug-eluting stents for peripheral arteries, and the growing adoption of minimally invasive peripheral vascular procedures.

Other key product segments in the global market include angioplasty catheters, guidewires, atherectomy devices, embolic protection devices, and vascular closure devices. Angioplasty catheters are used to perform angioplasty procedures by dilating narrowed arteries, while guidewires assist in navigating through blood vessels during interventional procedures. Atherectomy devices are employed to remove plaque buildup from arteries, whereas embolic protection devices help prevent the migration of plaque or blood clots during procedures. Vascular closure devices are used to achieve hemostasis and seal puncture sites in blood vessels post-intervention. The market for these products is driven by factors such as technological advancements, increasing prevalence of cardiovascular diseases, and a growing preference for minimally invasive procedures.

Global Interventional Cardiology and Peripheral Vascular Devices Market, Segmentation by Procedure

The Global Interventional Cardiology and Peripheral Vascular Devices Market has been segmented by Procedure into Iliac Intervention, Femoropopliteal Interventions, Tibial (Below-The-Knee) Interventions, Peripheral Angioplasty, Arterial Thrombectomy, and Peripheral Atherectomy.

Iliac interventions involve procedures that address blockages or narrowing in the iliac artery, a major artery in the pelvis that supplies blood to the lower limbs. These interventions are critical for improving blood flow in cases of peripheral artery disease (PAD), where plaque build-up can lead to significant health risks if untreated. Techniques such as angioplasty and stenting are commonly used to restore arterial patency, providing patients with relief from pain and reducing the risk of further complications.

Femoropopliteal interventions target the femoral and popliteal arteries, which run down the thigh and behind the knee, respectively. These arteries are common sites for blockages due to atherosclerosis. Procedures such as balloon angioplasty, stenting, and atherectomy help to reopen these arteries and enhance circulation to the lower extremities. Successful femoropopliteal interventions can significantly improve patients' mobility and quality of life, making these procedures a fundamental part of managing PAD.

Tibial (below-the-knee) interventions focus on treating arterial blockages located in the tibial arteries, which supply blood to the lower leg and foot. This type of intervention is particularly important for patients with severe PAD, as untreated tibial artery blockages can lead to non-healing ulcers, gangrene, and even limb amputation. Procedures in this category often involve advanced techniques, such as below-the-knee angioplasty and the use of specialized stents designed for smaller, more delicate arteries. These interventions are vital for maintaining limb salvage and preventing further complications in patients with advanced PAD.

Peripheral angioplasty is a minimally invasive procedure that involves the use of a balloon catheter to dilate narrowed or blocked blood vessels in the peripheral arteries. This procedure restores blood flow and is commonly performed in combination with stenting to maintain vessel openness. Peripheral angioplasty is utilized across different areas of the body, including the iliac, femoral, and tibial arteries, offering a versatile approach to treating vascular disease.

Arterial thrombectomy involves the removal of blood clots from arteries, a crucial procedure when a clot obstructs blood flow and leads to acute conditions such as acute limb ischemia. This intervention can be performed using mechanical thrombectomy devices that extract or break up the clot, improving blood circulation and preventing potential damage to the surrounding tissues. Arterial thrombectomy is particularly urgent and can be life-saving, as it aims to restore blood flow quickly and prevent permanent damage to the affected limb.

Peripheral atherectomy is a procedure that removes plaque buildup from the walls of peripheral arteries, helping to clear blockages and improve blood flow. This method can be used in various arterial locations and is often selected for cases where traditional angioplasty might be less effective. Peripheral atherectomy can be performed using different devices, including laser, rotational, and directional atherectomy systems. This technique is essential for treating patients with complex vascular blockages that require more extensive plaque removal for optimal results.

Global Interventional Cardiology and Peripheral Vascular Devices Market, Segmentation by Indication

The Global Interventional Cardiology and Peripheral Vascular Devices Market has been segmented by Indication into Peripheral Arterial Disease And Coronary Intervention.

Peripheral Arterial Disease (PAD) is a significant health concern that affects the peripheral arteries, often due to atherosclerosis. This condition can lead to reduced blood flow to the limbs, causing symptoms like pain, cramping, and in severe cases, ulcers and tissue death. PAD can result in serious complications such as gangrene, which may necessitate limb amputation. Peripheral vascular interventions, including angioplasty, stenting, and atherectomy, are commonly employed to restore proper blood flow, alleviate symptoms, and reduce the risk of further cardiovascular events. The treatment aims to improve the patient’s mobility, enhance quality of life, and prevent severe outcomes associated with advanced PAD.

Coronary Intervention pertains to procedures focused on treating blockages or narrowing in the coronary arteries, which supply blood to the heart muscle. Coronary artery disease (CAD) is a leading cause of heart attacks and can result in significant morbidity and mortality if untreated. Coronary interventions, such as percutaneous coronary interventions (PCI), include angioplasty, stent placement, and atherectomy to remove plaque and restore arterial patency. These procedures help improve blood flow to the heart, alleviate symptoms like angina, and reduce the risk of heart attacks. Advanced technologies and techniques are constantly evolving in this field to enhance procedural outcomes and patient recovery. Coronary interventions play a crucial role in managing CAD and preventing acute cardiac events, ensuring long-term heart health and patient survival.

Global Interventional Cardiology and Peripheral Vascular Devices Market, Segmentation by End User

The Global Interventional Cardiology and Peripheral Vascular Devices Market has been segmented by End User into Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories, Specialty Clinics and Others.

Hospitals constitute a significant portion of the end-user landscape, serving as primary centers for various cardiovascular interventions and procedures. Given their comprehensive infrastructure and multidisciplinary teams, hospitals are equipped to handle a wide range of cardiac and peripheral vascular conditions, making them pivotal in the adoption of interventional cardiology and peripheral vascular devices.

Ambulatory surgical centers (ASCs) represent another key end-user segment in this market. These facilities offer outpatient procedures, including certain interventional cardiology and peripheral vascular interventions, in a more convenient and cost-effective manner compared to traditional hospital settings. ASCs are increasingly being utilized for minor cardiac procedures, contributing to the overall market growth.

Cardiac catheterization laboratories (cath labs) serve as specialized units within hospitals and other healthcare facilities dedicated to performing diagnostic and interventional procedures for various cardiovascular conditions. Equipped with advanced imaging and monitoring technologies, cath labs play a crucial role in the delivery of minimally invasive cardiac interventions, driving the demand for interventional cardiology devices.

Specialty clinics focusing on cardiovascular care also constitute an important end-user segment. These clinics offer specialized services tailored to the diagnosis, treatment, and management of cardiovascular diseases, often complementing the services provided by hospitals and other healthcare facilities. As the prevalence of cardiovascular conditions continues to rise globally, the demand for interventional cardiology and peripheral vascular devices in specialty clinics is expected to grow.

The Others category encompasses various healthcare settings, such as academic medical centers, research institutions, and government healthcare facilities, where interventional cardiology and peripheral vascular devices are utilized for both clinical and research purposes. This segment reflects the diverse landscape of end users contributing to the utilization and advancement of these medical technologies.

Global Interventional Cardiology and Peripheral Vascular Devices Market, Segmentation by Geography

In this report, the Global Interventional Cardiology and Peripheral Vascular Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Interventional Cardiology and Peripheral Vascular Devices Market Share (%), by Geographical Region, 2024

In North America, the interventional cardiology and peripheral vascular devices market continues to lead globally owing to factors such as high prevalence of cardiovascular diseases, sophisticated healthcare infrastructure, and significant investments in research and development. The region is characterized by the presence of key market players, advanced technology adoption, and favorable reimbursement policies, driving market growth. Additionally, increasing awareness about preventive healthcare measures and rising demand for minimally invasive procedures contribute to the expansion of the market in this region.

Europe holds a substantial share in the global interventional cardiology and peripheral vascular devices market, driven by factors like the aging population, increasing incidence of lifestyle-related diseases, and supportive government initiatives. Countries such as Germany, France, and the UK are significant contributors to the market growth, with well-established healthcare systems and a high demand for advanced medical technologies. Moreover, strategic collaborations between industry players and healthcare providers further propel market expansion in the region.

The Asia Pacific region presents lucrative opportunities for the interventional cardiology and peripheral vascular devices market, fueled by rapid urbanization, improving healthcare infrastructure, and growing healthcare expenditure. Countries like China, Japan, and India are witnessing robust growth in demand for cardiovascular interventions due to lifestyle changes, rising disposable income, and increasing awareness about healthcare. Furthermore, initiatives by governments to enhance healthcare accessibility and affordability drive market penetration in this region.

In the Middle East and Africa (MEA) region, the interventional cardiology and peripheral vascular devices market is gradually evolving, supported by improving healthcare facilities, rising healthcare spending, and a growing burden of cardiovascular diseases. Despite challenges such as limited access to advanced medical technologies in certain areas, increasing investments by governments and private sector players to improve healthcare infrastructure are expected to fuel market growth. Additionally, collaborations with international companies for technology transfer and capacity building initiatives are likely to contribute to market development in the region.

Latin America represents a growing market for interventional cardiology and peripheral vascular devices, driven by factors such as the rising prevalence of cardiovascular diseases, improving healthcare infrastructure, and increasing awareness about minimally invasive treatment options. Countries like Brazil and Mexico are witnessing significant market growth due to favorable government policies, increasing healthcare expenditure, and the presence of key market players. Moreover, advancements in medical technology and a growing emphasis on preventive healthcare are expected to further boost market expansion in the region.

This report provides an in depth analysis of various factors that impact the dynamics of Global Interventional Cardiology and Peripheral Vascular Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers

• Technological advancements
• Increasing prevalence of cardiovascular diseases
• Growing aging population

• Rising demand for minimally invasive procedures: The global interventional cardiology and peripheral vascular devices market is witnessing a robust growth trajectory, largely propelled by the rising demand for minimally invasive procedures. Minimally invasive techniques have gained significant traction in recent years due to their numerous benefits over traditional surgical methods. These procedures offer shorter recovery times, reduced hospital stays, and lower risk of complications, making them increasingly preferred by both patients and healthcare providers.

  Advancements in technology have led to the development of innovative interventional cardiology and peripheral vascular devices, further driving market growth. These devices enable healthcare professionals to perform complex procedures with greater precision and efficacy. For instance, the introduction of drug-eluting stents has revolutionized the treatment of coronary artery disease by significantly reducing the risk of restenosis compared to bare-metal stents.

  The growing prevalence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, is fueling the demand for interventional cardiology and peripheral vascular devices. As the global population ages and lifestyles become increasingly sedentary, the incidence of these conditions is expected to rise, driving the need for effective treatment options. Consequently, manufacturers are investing in research and development activities to introduce innovative devices that address the evolving needs of patients and healthcare providers, further stimulating market growth.

Restraints

• High cost of devices
• Stringent regulatory requirements
• Limited reimbursement policies

• Lack of skilled healthcare professionals: The global interventional cardiology and peripheral vascular devices market has experienced substantial growth over the years, driven by technological advancements and the rising prevalence of cardiovascular diseases worldwide. However, one significant challenge facing this market is the lack of skilled healthcare professionals proficient in utilizing these advanced devices.

  Interventional cardiology procedures such as angioplasty and stent placements require specialized training and expertise. As these procedures become more complex with the introduction of newer devices and techniques, there is a growing demand for healthcare professionals who are adequately trained to perform them safely and effectively. However, the supply of such skilled professionals often lags behind, leading to longer wait times for procedures and potentially compromising patient care.

  The shortage of skilled healthcare professionals in interventional cardiology and peripheral vascular devices extends beyond physicians to include nurses, technologists, and support staff. These individuals play crucial roles in assisting during procedures, managing equipment, and providing post-operative care. A shortage of trained personnel in these roles can hinder the efficient functioning of interventional cardiology units and limit patient access to timely interventions.

Opportunities

• Emerging markets expansion
• Development of innovative devices
• Integration of AI and IoT

• Focus on preventive cardiology programs: The global interventional cardiology and peripheral vascular devices market is witnessing significant growth, driven by a heightened focus on preventive cardiology programs. As healthcare systems worldwide recognize the importance of proactive measures to combat cardiovascular diseases (CVDs), there's a growing emphasis on interventional cardiology devices aimed at both treatment and prevention. These devices play a crucial role in addressing a wide range of cardiovascular conditions, from coronary artery disease to peripheral artery disease, offering minimally invasive solutions that reduce patient recovery time and enhance overall outcomes.

  Preventive cardiology programs are gaining traction as healthcare providers increasingly prioritize strategies aimed at averting CVDs before they escalate into serious health crises. By integrating interventional cardiology devices into these programs, healthcare professionals can identify and address risk factors early on, implementing interventions such as angioplasty, stenting, and atherectomy to restore blood flow and prevent further complications. This proactive approach not only improves patient outcomes but also reduces the burden on healthcare systems by curbing the incidence of costly cardiac procedures and hospitalizations.

  Technological advancements in interventional cardiology and peripheral vascular devices are enhancing their effectiveness in preventive care. Innovations such as drug-eluting stents, bioresorbable scaffolds, and advanced imaging modalities enable more precise diagnosis and treatment planning, facilitating personalized interventions tailored to each patient's unique cardiovascular profile. As these technologies continue to evolve, supported by ongoing research and development efforts, the global market for interventional cardiology and peripheral vascular devices is poised for sustained growth, contributing to the advancement of preventive cardiology initiatives worldwide.

Key players in Global Interventional Cardiology and Peripheral Vascular Devices Market include:

• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• Johnson & Johnson
• Terumo Corporation
• B. Braun Melsungen AG
• Cardinal Health, Inc
• Cook Medical
• Edwards Lifesciences Corporation
• Penumbra, Inc

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis